Ajay Abad

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Manmeet S. Ahluwalia, David A. Reardon, Ajay Abad et al. · Journal of Clinical Oncology · 2022 · 159 citations · Full text

Medicine, Immunology, Oncology +17

Phase III study of first-line XELOX plus bevacizumab (BEV) for 6 cycles followed by XELOX plus BEV or single-agent (s/a) BEV as maintenance therapy in patients (pts) with metastatic colorectal cancer (mCRC): The MACRO Trial (Spanish Cooperative Group for the Treatment of Digestive Tumors [TTD]).

Josep Tabernero, Enrique Aranda, Alba Liliana Gil Gómez et al. · Journal of Clinical Oncology · 2010 · 39 citations

Medicine, Oncology, Pharmacology +8

Clinical and nutritional factors predictive of plasma lipid unsaturation deficiency in advanced liver cirrhosis: a logistic regression analysis.

Eduard Cabré, María Núñez, Ferrán Gónzalez‐Huix et al. · PubMed · 1993 · 26 citations

Agriculture, Nutrition, Nutritional Sciences +14

Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assay

Stephen Shuford, Lindsay Lipinski, Ajay Abad et al. · Neuro-Oncology Advances · 2021 · 25 citations · Full text

Medicine, Oncology, Pharmacology +16

Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma

Jeff F. Zhang, Bernard Okai, Austin J. Iovoli et al. · Journal of Neuro-Oncology · 2024 · 21 citations · Full text

Medicine, Oncology, Surgery +14